Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis
Condition: Arthritis, Psoriatic Interventions: Drug: Sonelokimab; Drug: Placebo; Drug: Adalimumab Sponsor: MoonLake Immunotherapeutics AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2022 Category: Research Source Type: clinical trials
